Navigation Links
Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products
Date:8/10/2009

BETHESDA, Md., Aug. 10 /PRNewswire-Asia/ -- Chindex International, Inc. ("Chindex") (Nasdaq: CHDX), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced that it has entered into two new exclusive, multi-year distribution agreements for China with Biotest AG and Cutera Inc.

Biotest AG, based in Dreieich, Germany (SDAX: BIO3), specializes in innovative hematology and immunology products. Biotest has appointed Chindex as the exclusive distributor for its unique Tango Optimo Automated Blood Bank System for the People's Republic of China. The Tango Optimo automates all routine testing procedures performed in blood banking, including blood grouping, antibody screening, and cross matching, and is the only blood bank analyzer that offers seven-day on-board storage of liquid and microplate reagents. Upon receipt of regulatory approval from China's State Food and Drug Administration, Chindex will market the Tango Optimo to hospital laboratories along with the Johnson & Johnson Ortho Clinical Diagnostics line of clinical chemistry analyzers.

Cutera Inc. (Nasdaq: CUTR) is a leading manufacturer of upgradeable, easy-to-use laser and other light-based aesthetic systems used by physicians and other qualified practitioners worldwide. Under the terms of the agreement, Chindex will market and distribute the upgradeable Xeo, Solera, and CoolGlide platforms in China and Hong Kong. The Cutera family of lasers, several of which have already been registered with the Chinese State Food and Drug Administration, provides an excellent complement to present Chindex product line.

Roberta Lipson, Chindex President and CEO, commented from Beijing, "We
'/>"/>

SOURCE Chindex International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Chindex International, Inc. Launches World-Class Cancer Treatment Center
2. Chindex International, Inc. to Report First Quarter Fiscal 2010 Financial Results
3. Chindex International and Vital Images Sign Reseller Agreement
4. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
5. Chindex International, Inc. Announces May Conference Participation
6. Chindex International, Inc. to Participate in the Piper Jaffray & ChinaVenture Investment Conference 2009
7. Chindex International, Inc. Reports Third Quarter FY 2009 Financial Results
8. Chindex International, Inc. to Participate in UBS Global Healthcare Services Conference
9. Chindex International, Inc. to Report Fiscal Third Quarter 2009 Financial Results
10. Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference
11. Chindex International, Inc. Adopts Voluntary Executive Compensation Restrictions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... November 28, 2014 The ... growth over the past five years. The industry ... of therapies that are either alternative to conventional ... to IBISWorld industry analyst David Whytcross, “industry revenue ... and growing private health insurance membership.” Meanwhile, improving ...
(Date:11/28/2014)... 28, 2014 Written and narrated by award ... Voices releases the “The Happiest Man In the World: ... account of how and why Project C.U.R.E. came to be. ... mother Josie and the Reverend Richard W. Jackson, Dr. Jackson ... of 30, but realized that he wasn’t happy. Prompted by ...
(Date:11/28/2014)... -- Planning on seconds at Thanksgiving Day dinner this year? ... gastroesophageal reflux disease (GERD) -- a few steps may help ... and throat specialist at Lenox Hill Hospital in New York ... Thanksgiving: Pace yourself. Rather than have ... the day. It,s also a good idea to have a ...
(Date:11/28/2014)... Not only is the Éminence Organic Skin ... parabens and other cancer-causing agents, but they are also ... awareness programs that help in the fight against breast ... an incredible, record-breaking contribution of $30,000 through participation in ... Sweet Red Rose Whip Moisturizer and the company’s corporate ...
(Date:11/28/2014)... An inventor and dental assistant from Kent, ... filling and it was almost impossible to reach. "This gave ... said. , The patent-pending Access Light allows for easier use ... of the mouth, as well as avoids harm to the ... to use and clean, it also helps prevent cross-contamination. , ...
Breaking Medicine News(10 mins):Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3
... toll from the mosquito-borne virus has risen to six in ... died of the disease in the paediatric ward of King ... the Farrukhabad district hospital,' V.S. Nigam, health department spokesman told ... cases has shot up to 199 in the state with ...
... villager suffering from a serious kidney ailment died Saturday ... hospital here//, apparently because he could not afford the ... a window of the nephrology ward of the Sanjay ... was being treated, hospital sources told IANS. ...
... lowered cholesterol levels are beneficial for the heart is ... the risk of prostate cancer// for men has only ... convinced that the two conditions are related, proving that ... prostate, too. ,Dr. William J. Catalona, director of ...
... Nile virus evades the body’s immune defenses by blocking ... could pave the way for a vaccine// to protect ... Medical Center researchers report. ,Researchers discovered the receptor’s ... a study, described in October’s Journal of Virology that ...
... Although Offensive breath is a common malady that many suffer ... scenario. In an all out effort to overcome it those ... food stuffs, which are notably notorious in causing bad breath//. ... cover it up, chewing gums, and mouth rinses are usually ...
... caught between the devil and the deep sea, unable to ... of emergency mental// healthcare. The patient, a 17 year old ... form of counseling was attempted. ,The girl suffered ... suicide attempts. According to the mother, her daughter was ...
Cached Medicine News:Health News:Cholesterol Levels affects Risk of Prostate Cancer 2Health News:Study Unveils West Nile Virus Immune Evasion, Points to Vaccine Development 2Health News:Study Unveils West Nile Virus Immune Evasion, Points to Vaccine Development 3
(Date:11/27/2014)... 2014 - New Solution That ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC ... 500,000 yen or $5,000 (without tax /including two pairs of ... is a dedicated solution of "JINS MEME" to academic researchers, ... data* generated by electrooculography and six-axis sensors without API. (*Physiological ...
(Date:11/26/2014)... 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced today that ... approximately $3.3 million at a price of $0.30 per ... focused investor. Each unit consists of one common share ... warrant. Each whole warrant entitles the holder to acquire ... a period of five years from closing.  ...
(Date:11/26/2014)... 2014  Genomic Health, Inc. (Nasdaq: GHDX ) ... Executive Officer and President, will participate in the 26 ... New York Palace Hotel in New York ... Eastern Time (ET). To access the live ... to the  Investor Relations  section of the company,s web ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3
... 8 Alpharma Inc. (NYSE: ALO ... results from,clinical trials that showed ALO-01 (EMBEDA(TM)) ... clinically relevant features addressing abuse liability,alongside a ... I and II,studies, presented at the 27th ...
... Annual Meeting of the American Pain Society ... ... with lacosamide,demonstrated sustained pain relief from diabetic neuropathic pain (DNP),compared to placebo-treated ... Pain Society (APS) in Tampa, Fla., "This is the first placebo-controlled ...
Cached Medicine Technology:Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4
... has the right product for any patient ... intubated patients to patients with tracheotomies. These ... and critical care applications., ,The Unti-Mist ... patients and staff members. This entire product ...
Passive heat and moisture exchangers for respiratory applications....
Passive heat and moisture exchangers for respiratory applications....
Ballard trach care HMES and filters, tv 1500, HME...
Medicine Products: